Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer-associated amyloid plaques in the brain

Fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10 percent

Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age

Bilateral theta burst stimulation noninferior to standard bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression

Findings for pharmacotherapy, psychotherapy, or combination treatment

Exposure to Hurricane Sandy in utero linked to increased risk for depressive disorders, anxiety disorders, attention-deficit/behavioral disorders

Largest decreases seen in Native American, Black, and Hispanic individuals